Mutations in alpha-and beta-tubulins are increasingly recognised as a major cause of malformations of cortical development (MCD), typically lissencephaly, pachygyria and polymicrogyria; however, sequencing tubulin genes in large cohorts of MCD patients has detected tubulin mutations in only 1-13%. We identified patients with a highly-characteristic cerebellar dysplasia but without the lissencephaly, pachygyria and polymicrogyria typically associated with tubulin mutations. Remarkably, in 7 of 9 patients (78%), targeted sequencing revealed mutations in three different tubulin genes (TUBA1A, TUBB2B, TUBB3), occurring de novo or inherited from a mosaic parent. Careful re-review of the cortical phenotype on brain imaging revealed only an irregular pattern of gyri and sulci, for which we propose the term tubulinopathy-related dysgyria. Basal ganglia (100%) and brainstem dysplasia (80%) were common features. Based on in silico structural predictions, the mutations affect amino acids in diverse regions of the alpha/beta-tubulin heterodimer, including the nucleotide binding pocket.
roles for the three tubulin genes involved. Identifying this highly characteristic phenotype is important due to the low recurrence risk compared to the other (recessive) cerebellar dysplasias and the apparent lack of non-neurological medical issues.
Introduction
Since the first discovery in 2007 of TUBA1A (OMIM *602529) as a novel gene for lissencephaly, genes encoding alpha-and beta-tubulins, the main components of microtubule polymers, are now being recognised for their major involvement in malformations of cortical development (MCD) (1, 2) and these disorders are now collectively termed tubulinopathies.
Mutations in TUBA1A are predominantly associated with a variable spectrum of lissencephaly, pachygyria, and polymicrogyria-like cortical malformations, with or without microcephaly and abnormalities of other brain structures (in particular the basal ganglia and corpus callosum) (1, 3, 4, 5, 6, 7, 8, 9, 10, 11) . TUBB2B (OMIM *612850) mutations frequently cause polymicrogyrialike abnormalities, as well as lissencephaly, cortical dysplasia, schizencephaly, and microcephaly to a lesser extent (12, 13, 14, 15, 16, 17) . Two major subgroups of TUBB3 (OMIM *602661) mutations have been previously described: those associated with mildly abnormal gyral pattern (microgyria, gyral disorganization), and those with congenital fibrosis of the extraocular muscles type 3 (CFEOM3) with neurological symptoms (2, 18, 19) . Mutations in TUBB (OMIM Clinically, individuals with tubulin mutations display a range of outcomes, from severe intellectual disability and intractable seizures to learning difficulties and absence of epilepsy (12, 16, 18) . Screening tubulin genes in large cohorts of MCD patients has yielded a mutation detection rate of only 1-13.3% (6, 8, 9, 12, 13) . Selection of MCD patients for sequencing of these genes is difficult because of the variable clinical and imaging features.
It is clear, however, that overall brain development is affected in these patients and, besides predominant cortical malformations, the basal ganglia, corpus callosum, brain stem, and cerebellum are frequently affected. The cerebellum and vermis are often described as hypoplastic or dysplastic, without further specification of the abnormality (6, 19) . The range of overlapping phenotypes stemming from tubulin gene variation has been examined extensively; however, all studies published to date have ascertained patients based exclusively on the presence of MCD.
In this study, we present ten patients ascertained due to their characteristic cerebellar dysplasia combined with basal ganglia dysplasia and frequently brainstem asymmetry. Although lissencephaly, pachygyria and polymicrogyria-like malformations were absent, this combination of imaging features prompted us to sequence tubulin genes. Strikingly, this yielded a high mutation detection rate; as seven out of nine patients carry tubulin mutations (78%, six of eight families). 
Results
From the large cohort of patients with hindbrain imaging abnormalities referred to the University of Washington Hindbrain Research Program, we identified ten patients, including two siblings, with a distinct combination of brainstem asymmetry, superior cerebellar dysplasia and basal ganglia dysplasia and without a diagnosis of MCD (e.g. pachygyria, polymicrogyria).
Clinical features
All individuals displayed delayed psychomotor development, with a broad range of severity (Table 1) . Motor development was usually more affected than speech. Four patients had documented seizures. Four were reported to have significant behavioural problems, ADHD and aggression being most common. OFC was available for nine individuals, five of whom had microcephaly (>2 standard deviations below the mean) and two of whom had macrocephaly (>2 standard deviations above the mean). Of note, abnormal eye movements were recorded in seven individuals, including oculomotor apraxia (OMA) in four. Strabismus was present in five.
Polyneuropathy and/or congenital fibrosis of the extraocular muscles (CFEOM) were not reported in any of the patients. No patients had dysmorphic features, non-central nervous system malformations or hearing loss.
Brain imaging
Brain MRI studies were performed between eight months and eight years of age for all ten individuals (Table 2) . 
Cerebellum and cerebellar vermis
All patients have a distinct dysplasia of the superior cerebellum, especially the vermis (with "diagonal" folia, i.e. folia crossing the midline at an oblique angle), best visible at the midline on axial views ( Supplementary Fig.1 , see also Fig. 1 & Supplementary Fig.2, 2 nd column). The vermis is hypoplastic in all but three individuals (7/10), with the anterior vermis more severely affected. The cerebellar hemispheres are either normal size or mildly hypoplastic with mild asymmetry.
Brainstem
In eight of 10 individuals, the pons is asymmetrically hypoplastic with a midline ventral indentation and asymmetrical inferior and middle cerebellar peduncles. Additional diffusion tension imaging (DTI) studies of individual UW165-3 showed asymmetry of the corticospinal tracts at the level of the pons ( Supplementary Fig. 3 ). In five of ten, the medulla has a globular contour, with indistinct demarcation between the pyramids and the olivary nuclei.
Basal ganglia, thalami, and corpus callosum
The basal ganglia are asymmetrically dysplastic with bulbous appearance in all individuals, with diffuse, branched, or absent anterior limb of the internal capsule ( Fig. 1 & Supplementary Fig. 2 , 3rd column). The lateral ventricles have an irregular contour and abnormal rounding of the frontal horns (10/10), likely related to the basal ganglia dysplasia. The thalami are globularshaped in all. The corpus callosum is variably affected, ranging from almost complete agenesis to normal ( Fig. 1 & Supplementary Fig. 2 , 4 th column).
Cortex
As cortical malformations are considered a key feature in the tubulinopathies, but not reported in our cohort, we carefully re-reviewed the cortex in all individuals. Lissencephaly, pachygyria, and 4 ). Variants were determined to be absent from 1,000 genomes, the Exome Variant Server, dbSNP142 and ExAC databases. We did not identify mutations in TUBA8, TUBB2A or TUBB4A.
CADD scores were generated for each mutation and previously published disease-associated tubulin gene variants (Supplementary 
Homology Modelling
Altered amino acids are located in a variety of positions throughout the alpha/beta-tubulin heterodimer ( TUBB3: p.Glu288Lys is located within the 9 th alpha-helix of the beta-tubulin subunit. When incorporated within a microtubule polymer, the acidic glutamate side chain is orientated laterally towards a beta-tubulin subunit of an adjacent protofilament. This residue is conserved through both alpha-and beta-tubulins, and substitution with a basic lysine residue is predicted to disrupt two putative hydrogen bonds between Glu288 and Thr285 within the same subunit ( Supplementary Fig. 7 ). TUBB3, p.Pro357Leu affects one of two neighbouring prolines in a loop between beta-strands 9 and 10 of the beta-tubulin subunit. When incorporated within polymer lattice, Pro357 faces into the microtubule lumen ( Fig. 2 B) . This residue is not predicted to interact with longitudinal or laterally adjacent tubulin subunits.
Effect of tubulin gene variants on microtubule incorporation and polymerisation in vitro
To investigate the in vitro functional consequences of tubulin gene variants identified, wildtype and variant TUBA1A, TUBB2B and TUBB3 constructs were transiently-expressed in HEK293 cells and immunocytochemically stained with antibodies specific to endogenous and transgenic tubulin. Mutations had variable effects on co-assembly with endogenous alpha-or beta-tubulin subunits and incorporation into microtubule polymers ( Fig. 3 & Table 3 ). 
Discussion
This study describes a highly recognisable pattern of cerebellar dysplasia, brainstem asymmetry and basal ganglia dysplasia without major cortical malformation in 10 patients with developmental delays and eye movement abnormalities. In the majority of tested patients (78%)
we identified mutations in TUBA1A, TUBB2B or TUBB3 that were either de novo or inherited from a mosaic parent. Four out of five mutations identified are novel. Our data add a distinct and recognizable phenotype to the tubulinopathy spectrum, with relatively mild cortical involvement (12). Although the cohort presented is small, the mutation detection rate suggests that the described pattern of brain abnormalities is highly predictive for tubulin mutations. This detection rate is much higher than any previously published in patients with cortical malformations, ranging from 1-13.3% (6, 8, 9, 12, 13) . We expect this number to be higher in selected cohorts of patients with cortical malformations combined with other abnormalities, (e.g. of basal ganglia, corpus callosum) and indeed a detection rate of 30% has been found for the combination of lissencephaly with cerebellar hypoplasia (6) .
Clinical implications
The While previous studies have not focused on cerebellar abnormalities in tubulinopathies, cerebellar dysplasia has been mentioned in multiple patients (all with cortical malformations), confirming its association with tubulin gene mutations (11, 12, 15, 16, 19) . In another study, up to 30% of patients with lissencephaly with cerebellar hypoplasia had mutations in TUBA1A, as opposed to only 1% in the classic lissencephaly cohort (6) . It would be interesting to investigate whether cerebellar dysplasia (without hypoplasia) is also a useful diagnostic marker for tubulin mutations in patients with lissencephaly.
While OMA is commonly present in patients with cerebellar abnormalities, OMA has rarely been associated with tubulinopathies, so it is surprising that the majority of our patients presented with gross motor delays and OMA or other impairments of eye movement. In contrast, OMA has only been described in two patients with the distinct tubulinopathy H-ABC 
Subtle cortical dysgenesis: dysgyria
No findings of lissencephaly, pachygyria, cobblestone cortex, or polymicrogyria (abnormal cortical thickness, irregular cortical surface and grey-white boundary and/or microgyri) were present in the individuals recruited for this study (24). However we observed abnormal sulci, the majority being shallow, with less frequent areas of sulci extending too deeply into the white matter, the latter predominantly in the perisylvian areas. We therefore consider the terms simplified gyral pattern, polymicrogyria, and polymicrogyria-like cortical dysplasia to be potentially confusing. This is also supported by foetal pathology studies showing atypical features in polymicrogyria-like cortical dysplasia, suggesting a different pathophysiological mechanism from classic polymicrogyria (11, 13). We propose using the term tubulinopathyassociated dysgyria for the subtle abnormalities of gyral shape without imaging evidence of lissencephaly, pachygyria, cobblestone cortex, polymicrogyria, or other cortical abnormalities.
Recurrence risk
We identified two affected siblings with a TUBB2B mutation, inherited from an asymptomatic father who was found to be mosaic for this mutation. Familial recurrence has previously been described in two sisters with polymicrogyria and a TUBA1A mutation with mosaicism in the maternal line (5 
Genotype-phenotype correlations
The same tubulin mutations are frequently observed in unrelated individuals sharing similar brain malformations, e.g. TUBA1A p.Arg264Cys in individuals with characteristic central pachygyria (3, 9, 12). Substitutions affecting identical residues but resulting in different amino acids have also produced comparable phenotypes (e.g. TUBA1A p.Arg402Cys and p.Arg402His (6, 12) . Consistent with this, in our cohort of patients with strikingly similar MRI findings, we identified one (TUBB3 p.Pro357Leu) mutation in two unrelated patients and a second mutation (TUBB2B p.Gly13Ala) in two siblings. Contrary to this trend, the TUBA1A p.Arg214His variant found in UW168-3 was previously identified in a foetus with a more severe phenotype (11, 12). Other phenotypic dissimilarities have also been described, e.g. TUBA1A p.Arg390Cys associated with both tubulinopathy-associated dysgyria (6) and asymmetrical perisylvian polymicrogyria (10). While these instances are relatively uncommon, they limit the utility of genotype-phenotype correlations in clinical practice.
The large number of TUBA1A mutations that have been identified to date (49 at present), the majority of which are associated with severe brain malformations, makes it possible to evaluate whether in silico predictions such as CADD scores correlate with severity of the brain malformation. In fact, the TUBA1A variants associated with subtle cortical abnormalities have lower CADD scores than those associated with microlissencephaly, so it may someday be possible to use in silico predictions to improve prognostic information for patients and families.
Functional effects of mutations
Our data indicate that mutations in three different tubulin genes lead to a very consistent clinical phenotype, implicating a shared biological mechanism. Surprisingly, the mutations also affect diverse regions of the alpha/beta-tubulin heterodimer, resulting in potential effects on microtubule dynamics, polymer incorporation or guanine nucleotide binding. TUBA1A
p.Arg214His was associated with the mildest functional deficit in our in vitro pipeline, incorporating into microtubule polymers at comparable levels to wild-type but at a reduced rate.
This mild deficit is consistent with the predicted subtle structural effects of TUBA1A 
Conclusion
In summary, we have identified a highly characteristic combination of cerebellar, brainstem, basal ganglia abnormalities with subtle cortical involvement associated with mutations in three 
Materials & Methods

Patient selection
From the large cohort of patients with hindbrain imaging abnormalities referred to the University of Washington Hindbrain Research Program, we identified patients with a distinct combination of brainstem asymmetry, superior cerebellar dysplasia and basal ganglia dysplasia and without a diagnosis of MCD (e.g. pachygyria, polymicrogyria). Clinical information was collected through chart review and structured interviews with the parents. All MRIs were systematically reviewed for abnormalities of the cortex, basal ganglia, white matter, ventricles, corpus callosum, hippocampus, brainstem, cerebellum, cerebellar vermis, and cranial nerves (by RO, GI, DD). When possible, DNA was collected from blood and/or saliva. Patients were enrolled through a human subjects research protocol approved at the University of Washington.
Informed consent was provided by the patients, their parents or their legal guardians. 
Bioinformatics Analysis of Tubulin Gene Variants
Homology Modelling
In silico structural predictions of wild-type and variant TUBA1A, TUBB2B and TUBB3
proteins were generated via a previously described homology modelling pipeline (27 
Cell Culture
Human Embryonic Kidney (HEK293) cell culturing, seeding and transfection were performed as previously described (22).
Expression Construct Generation
In vitro functional analysis of TUBA1A and TUBB2B variants was performed using expression constructs derived from a C-terminally FLAG-tagged TUBA1A (pRK5TUBA1A-CFLAG) clone as previously published (6). pRK5TUBA1A-FLAG was subsequently modified to reflect wild-type TUBB2B (pRK5TUBB2B-CFLAG) by directional cloning. Tubulin gene variants were introduced into wild-type TUBA1A and TUBB2B, as well as a C-terminally DDKtagged human TUBB3 expression construct (OriGene Technologies; pCMV6 entry), using
QuickChange site-directed mutagenesis (Stratagene, UK). Entire wild-type and variant transgene coding regions were sequence validated following maxiprep yields (QIAgen). The TUBA1A p.Ile219Val variant was only identified in the final stages of this study and in vitro analysis was therefore not available. We included this patient due to the position of the affected amino acid, its de novo inheritance, and the similarity of the resulting phenotype with that of others in the cohort. 
Immunocytochemistry
Microtubule Polymerisation Assay
HEK293 cells expressing wild-type and variant tubulin gene constructs were incubated at 4 o C to induce depolymerisation of the microtubule polymer network. After 30 minutes, HEK293s were returned to 37 o C. At specified times following their return to optimal temperature, cells were removed, methanol fixed and immunostained to observe the rate of microtubule repolymerisation in the presence of each tubulin construct.
Supplementary Information
Supplementary Material is available at HMG online. 
